Why can the patient still achieve erections one month after a prolonged ischemic priapism episode, given residual cavernous smooth‑muscle viability, arterial inflow, and prior PDE‑5 inhibitor use?

Residual Erectile Function After Prolonged Ischemic Priapism

The patient can still achieve erections one month after prolonged ischemic priapism because some cavernous smooth muscle remains viable despite the ischemic injury, preserved arterial inflow continues to support partial erectile function, and prior PDE-5 inhibitor use may have provided some protective conditioning of the erectile tissue.

Understanding the Paradox of Preserved Function

The traditional teaching that ischemic priapism >36 hours results in complete, permanent erectile dysfunction is not absolute. While the 2021 AUA/SMSNA guidelines clearly state that patients with priapism >36 hours have "permanent ED with no recovering erectile function" 1, this represents the most likely outcome, not an invariable one.

Key Mechanisms Explaining Residual Function

Incomplete smooth muscle necrosis: The ischemic injury in prolonged priapism is not uniformly distributed throughout the corpora cavernosa. Recent evidence challenges the rigid 4-6 hour timeline for irreversible damage 2. While smooth muscle edema and atrophy begin as early as 6 hours 1, complete necrosis requiring 48+ hours may leave islands of viable tissue that can still respond to arterial inflow and neural stimulation.

Preserved arterial inflow: Even after prolonged ischemia, the arterial supply to the penis typically remains intact. If any functional smooth muscle survives, adequate arterial pressure can still generate partial tumescence. The corpus spongiosum and glans are typically spared in ischemic priapism 1, and collateral blood flow may support residual erectile capacity.

PDE-5 inhibitor preconditioning effect: Prior PDE-5 inhibitor use may have provided protective benefits. Studies demonstrate that chronic PDE-5 inhibitor therapy "reconditions PDE5 regulatory function in the penis" 3, 4. This preconditioning may have:

• Enhanced nitric oxide-mediated smooth muscle relaxation pathways
• Improved endothelial function
• Reduced the severity of ischemic injury during the acute event
• Preserved some degree of erectile tissue responsiveness

Clinical Reality vs. Guidelines

Important caveat: The guidelines emphasize that priapism >36 hours typically results in permanent ED 1, but this reflects population-level outcomes. Individual variation exists based on:

• Degree of rigidity during the episode: Partially rigid erections cause less ischemic damage than fully rigid ones 5
• Intermittent detumescence: Brief periods of spontaneous detumescence during the prolonged episode may have allowed reperfusion
• Individual vascular anatomy: Collateral circulation varies between patients
• Speed and effectiveness of initial interventions: Even delayed treatment may salvage some tissue

The Role of PDE-5 Inhibitors Post-Event

The patient's continued ability to achieve erections may be further supported by ongoing PDE-5 inhibitor use. Evidence shows that "regimented PDE5 inhibitor therapy was an impactful treatment" with 92% of patients reporting improvement 6. While this study focused on recurrent priapism prevention, the mechanism—regularizing PDE5 function—applies to post-ischemic recovery as well 3.

Prognostic Implications

This residual function should not create false reassurance. The 2021 guidelines are explicit: erectile dysfunction is "the most significant complication in patients with prolonged acute ischemic priapism" 1. Even with current erections, the patient faces:

• Progressive corporal fibrosis over time
• Declining erectile quality as fibrotic tissue replaces smooth muscle
• Penile shortening from tissue contracture
• Potential complete loss of function within months to years

Critical counseling point: The patient should understand that current erectile ability does not indicate full recovery. Treatment delay exceeding 48 hours is an independent predictor of poor erectile outcomes 7, and the natural history involves progressive deterioration.

Management Moving Forward

The patient requires:

1. Realistic expectations: Current function may deteriorate
2. Aggressive erectile rehabilitation: Daily low-dose PDE-5 inhibitors (tadalafil 5mg daily or sildenafil 25-50mg daily) to maximize remaining smooth muscle function 6, 3
3. Close monitoring: Serial assessment of erectile quality using validated instruments (IIEF-5)
4. Early prosthesis counseling: If function declines, early penile prosthesis implantation (before severe fibrosis develops) offers better outcomes than delayed surgery 8, 9

The preserved erectile function at one month represents partial tissue survival and favorable individual factors, but does not negate the serious long-term prognosis established by the duration of the ischemic event.